Comparable stake leader
Growth Equity Opportunities 17, LLC
SEC ownership of Savara Inc
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001160308.
Disclosed value leader
NEA Management Company, LLC
Comparable rows
50/50
Latest evidence
31 Mar 2026
- Public ticker
- SVRA on Nasdaq
- Parsed ownership sources
-
3/4/5, 13D/G, and 13F
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Growth Equity Opportunities 17, LLC
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
50 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
Growth Equity Opportunities 17, LLC
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
31 Mar 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001160308
- Issuer location
- Austin, TX
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Savara Inc (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Growth Equity Opportuniti...
Disclosed value leader
NEA Management Company, LLC
Comparable rows
50/50
Latest evidence
31 Mar 2026
3/4/5
13D/G
13F
Lead comparable stake: 12%
13D/G row: Growth Equity Opportunities 17, LLC
Showing 1-8 of 50 holder rows.
Quick read
Growth Equity Opportunities 17, LLC leads the comparable SEC ownership view at 12%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Growth Equity Opportunities 17, LLC's linked filing trail.
Comparable ownership
Top 5
Growth Equity Opportunities 17, LLC
12%
Bain Capital Life Sciences Fund I...
10%
Venrock Healthcare Capital Partne...
9.9%
Farallon Capital Partners, L.P.
6.9%
James E. Flynn
6.7%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Growth Equity Opportunities 17, LLC |
3/4/5
13D/G
10%+ Owner
|
12%
from 13D/G
|
$108,897,125
24,471,264 shares
|
— | 17 Jul 2023 |
| Bain Capital Life Sciences Fund II, L.P. |
13D/G
|
10%
|
$55,969,975
17,600,621 shares
|
$0 | 25 Mar 2025 |
| Venrock Healthcare Capital Partners III, L.P. |
13D/G
|
9.9%
|
$123,617,225
20,881,288 shares
|
+$48,545,450 | 31 Dec 2025 |
| Farallon Capital Partners, L.P. |
13D/G
Dapice Joshua J.
|
6.9%
|
$90,445,500
15,000,000 shares
|
-$19,831,599 | 31 Dec 2025 |
| James E. Flynn |
13D/G
Deerfield Mgmt, L.P.
|
6.7%
|
$48,441,330
13,569,000 shares
|
$0 | 30 Oct 2025 |
| TCG Crossover GP I, LLC |
13D/G
|
6.1%
|
$73,184,254
12,362,205 shares
|
$0 | 31 Dec 2025 |
| BlackRock, Inc. |
13D/G
13F
Company
|
5.4%
|
$66,069,364
10,957,322 shares
|
+$15,933,163 | 31 Dec 2025 |
| Frazier Life Sciences Public Fund, L.P. |
13D/G
|
4.1%
|
$49,390,844
8,343,048 shares
|
+$9,458,692 | 31 Dec 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$2,362,652.
Buys
$0
Insiders: 0
Sells
$2,362,652
Insiders: 2
Net
-$2,362,652
Shares: -414,528
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 414,528
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 394,528 | $0 | $2,241,432 | -$2,241,432 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 20,000 | $0 | $121,220 | -$121,220 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-20 of 25 reporting-owner rows connected to Savara Inc. Open a relationship link for the CIK-to-CIK filing trail.
Rows
25
Largest Forms 3/4/5 holder
Forest Baskett
Net 12M change
-$2,362,652
Latest report
15 Jul 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Forest Baskett | 10%+ Owner | $108,897,125 | Mixed | 17 Jul 2023 | ||
| Scott D. Sandell | 10%+ Owner | $108,897,125 | Mixed | 17 Jul 2023 | ||
| Carmen Chang | 10%+ Owner | $108,897,125 | Mixed | 17 Jul 2023 | ||
| Ali Behbahani | 10%+ Owner | $108,897,125 | Mixed | 17 Jul 2023 | ||
| Mohamad Makhzoumi | 10%+ Owner | $108,897,125 | Mixed | 17 Jul 2023 | ||
| Growth Equity Opportunities 17, LLC | 10%+ Owner | $108,897,125 | Mixed | 17 Jul 2023 | ||
| Mathers Edward T. | 10%+ Owner | $108,897,125 | Mixed | 17 Jul 2023 | ||
| Anthony A. Florence Jr. | 10%+ Owner | $108,897,125 | Mixed | 17 Jul 2023 | ||
| Paul Edward Walker | 10%+ Owner | $108,897,125 | Mixed | 17 Jul 2023 | ||
| Rick Yang | 10%+ Owner | $108,897,125 | Mixed | 17 Jul 2023 | ||
| David A. Ramsay | Director | $15,356,404 | -$121,220 | -0.78% | Filing P/S | 19 Dec 2025 |
| Matthew Pauls | CHIEF EXECUTIVE OFFICER, Director | $6,118,457 | Mixed | 14 Dec 2025 | ||
| Kathleen R. McCabe | Chief Legal Officer | $3,593,085 | Mixed | 14 Dec 2025 | ||
| David L. Lowrance | Chief Financial Officer | $3,045,358 | -$2,241,432 | -42% | Filing P/S | 22 Jun 2026 |
| Anne Erickson | Chief Business Officer | $2,572,247 | Mixed | 14 Dec 2025 | ||
| Robert Matthew Lutz | Chief Fin. & Operating Officer | $2,026,498 | Median | 15 Jul 2026 | ||
| Badrul A. Chowdhury | Chief Medical Officer | $1,335,000 | Mixed | 14 Dec 2021 | ||
| Raymond Dennis Pratt | Chief Medical Officer | $1,124,103 | Mixed | 12 Dec 2024 | ||
| Yasmine Wasfi | Chief Medical Officer | $1,070,210 | Mixed | 04 Dec 2025 | ||
| Richard J. Hawkins | Director | $577,547 | Mixed | 09 Dec 2025 |
Recent insider transactions for Savara Inc
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Robert Matthew Lutz | SVRA | Common Stock | Award | 11.9% | 35,000 | 328,977 | 15 Jul 2026 | Direct | ||
| Robert Matthew Lutz | SVRA | Stock Option (Right to Buy) | Award | 70,000 | 70,000 | 15 Jul 2026 | Direct | |||
| David L. Lowrance | SVRA | Common Stock | Sale | -42.4% | $2,241,432 | $5.68 | -394,528 | 536,032 | 22 Jun 2026 | Direct |
| David L. Lowrance | SVRA | Common Stock | Tax liability | -24% | -185,659 | 589,350 | 22 Jun 2026 | Direct | ||
| David L. Lowrance | SVRA | Common Stock | Options Exercise | 143.7% | 580,187 | 983,947 | 22 Jun 2026 | Direct | ||
| David L. Lowrance | SVRA | Stock Option (Right to Buy) | Options Exercise | -100% | -580,187 | 0 | 22 Jun 2026 | Direct | ||
| David L. Lowrance | SVRA | Common Stock | Tax liability | -25.4% | -116,760 | 342,555 | 18 Mar 2026 | Direct | ||
| David L. Lowrance | SVRA | Common Stock | Options Exercise | 197.4% | 366,747 | 552,550 | 18 Mar 2026 | Direct | ||
| David L. Lowrance | SVRA | Stock Option (Right to Buy) | Options Exercise | -100% | -366,747 | 0 | 18 Mar 2026 | Direct | ||
| Joseph S. McCracken | SVRA | Common Stock | Options Exercise | 0.6% | 1,807 | 302,644 | 16 Feb 2026 | Direct | ||
| Joseph S. McCracken | SVRA | Stock Option (right to buy) | Options Exercise | -100% | -1,807 | 0 | 16 Feb 2026 | Direct | ||
| David A. Ramsay | SVRA | Common Stock | Sale | -0.78% | $121,220 | $6.06 | -20,000 | 2,533,642 | 19 Dec 2025 | Direct |
| David L. Lowrance | SVRA | Common Stock | Gift | -10.1% | -32,000 | 286,045 | 16 Dec 2025 | Direct | ||
| Matthew Pauls | SVRA | Common Stock | Gift | -9.79% | -128,995 | 1,188,050 | 16 Dec 2025 | Direct | ||
| David L. Lowrance | SVRA | Common Stock | Tax liability | -16.5% | -62,960 | 318,045 | 14 Dec 2025 | Direct | ||
| Matthew Pauls | SVRA | Common Stock | Tax liability | -12.9% | -195,705 | 1,317,045 | 14 Dec 2025 | Direct | ||
| Robert Matthew Lutz | SVRA | Common Stock | Tax liability | -18.7% | -67,760 | 293,977 | 14 Dec 2025 | Direct | ||
| Kathleen R. McCabe | SVRA | Common Stock | Tax liability | -7.04% | -39,350 | 519,232 | 14 Dec 2025 | Direct | ||
| Anne Erickson | SVRA | Common Stock | Tax liability | -14.5% | -62,960 | 371,712 | 14 Dec 2025 | Direct | ||
| Matthew Pauls | SVRA | Common Stock | Gift | -1.54% | -23,629 | 1,512,750 | 10 Dec 2025 | Direct | ||
| Richard J. Hawkins | SVRA | Common Stock | Award | 33% | 40,000 | 161,326 | 09 Dec 2025 | Direct | ||
| An van Es-Johansson | SVRA | Common Stock | Award | 64% | 40,000 | 102,500 | 09 Dec 2025 | Direct | ||
| Nevan C. Elam | SVRA | Common Stock | Award | 59.8% | 40,000 | 106,887 | 09 Dec 2025 | Direct | ||
| David A. Ramsay | SVRA | Common Stock | Award | 1.59% | 40,000 | 2,553,642 | 09 Dec 2025 | Direct | ||
| Joseph S. McCracken | SVRA | Common Stock | Award | 15.3% | 40,000 | 300,837 | 09 Dec 2025 | Direct | ||
| Yasmine Wasfi | SVRA | Common Stock | Tax liability | -11.6% | -21,992 | 168,008 | 04 Dec 2025 | Direct | ||
| Nevan C. Elam | SVRA | Common Stock | Tax liability | -2.15% | -1,473 | 66,887 | 02 Dec 2025 | Direct | ||
| Nevan C. Elam | SVRA | Common Stock | Options Exercise | 9.38% | 5,860 | 68,360 | 02 Dec 2025 | Direct | ||
| Nevan C. Elam | SVRA | Stock Option (Right to Buy) | Options Exercise | -100% | -5,860 | 0 | 02 Dec 2025 | Direct | ||
| Richard J. Hawkins | SVRA | Common Stock | Options Exercise | 5.08% | 5,860 | 121,326 | 14 Nov 2025 | Direct | ||
| Richard J. Hawkins | SVRA | Stock Option (Right to Buy) | Options Exercise | -100% | -5,860 | 0 | 14 Nov 2025 | Direct | ||
| Yasmine Wasfi | SVRA | Common Stock | Award | 22.6% | 35,000 | 190,000 | 20 Oct 2025 | Direct | ||
| Yasmine Wasfi | SVRA | Stock Option (Right to Buy) | Award | 70,000 | 70,000 | 20 Oct 2025 | Direct |
* marks a reported price that did not pass the local price check.